Skip to content

A stack by quietlifter

Mitochondrial output and NAD salvage

MOTS-c and NAD+ get combined on the reasoning that one signals mitochondrial stress and the other supplies the coenzyme. That reasoning is plausible and untested in combination.

Proposed8 weeks2 compounds

quietlifter wrote this as a plan rather than a record. There is no dose log behind it, and nothing here says anybody followed it.

The schedule

Each compound in Mitochondrial output and NAD salvage, with dose and schedule.
CompoundDoseHow oftenWeeks
MOTS-c10 mgWeekly · Mon, Wed, Fri18
NAD+Subcutaneous rather than the infusions most of the human reporting uses. Those are not the same exposure.100 mgWeekly · Tue, Fri18

Read thisThis is one person’s plan, published by them. We did not write it, check it, or verify that they followed it — and one person doing something is not evidence that it works or that it is safe. Every compound above links to what the published research actually says.

Report this

Tell us what is wrong with this page. Reports go to a person, not a filter. Read the content policy if you want to know what we act on and what we do not.

Why

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice.

1 comment

Written by readers, not by us. Nothing here is checked, and a confident reply is not evidence.

  • mendtherapy

    3 Sept 2026

    The NAD+ note is the important one. Nearly all the human reporting on NAD+ is intravenous infusions over an hour or more, and subcutaneous at a tenth of the dose is not a smaller version of that — it is a different exposure that nobody has characterised.

Create an account to comment. Reading takes none.